AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

CABERGOLINE 0.500 Mg ;

13 registrations across 1 African market— 13 active

Markets with CABERGOLINE 0.500 Mg ;

Recent registrations

Brand / ProductMarketHolderStatusExpires
Ergolex
Tablets
🇪🇬EgyptUnited Pharma Companyactive
HYPOLACT 0.5mg tabs.
Tablets
🇪🇬EgyptAl ansar Marketing Company - A.M.Cactive
Prolactifix
Tablets
🇪🇬EgyptBiofactoractive
GOLINOSAB 0.5 mg
Tablets
🇪🇬EgyptNexus international pharmaceuticalsactive
Elonda
Tablets
🇪🇬EgyptGlobe International Pharmaceuticalsactive
Ergolex
Tablets
🇪🇬EgyptUnited Pharmactive
Marvigoline
Tablets
🇪🇬EgyptThe Tenth of Ramadan for Pharmaceutical Industries & Diagnostic Reagents "RAMEDA"active
DELCABRIN
SCORED TABLET
🇪🇬EgyptHealth well egyptactive
Elonda
Tablets
🇪🇬EgyptGlobe International Pharmaceuticalsactive
Dostilact
Tablets
🇪🇬EgyptOmega pharmaceutical and chemical industries - OPCIactive
REMIGOLINE 0.5mg
Tablets
🇪🇬EgyptHochster pharmaceutical industriesactive
Nostifix
Tablets
🇪🇬EgyptMarcyrl pharmaceutical industries - MPIactive
JAKARANDA
Tablets
🇪🇬Egyptcopad egypt for trade and pharmaceutical industries (copad pharma)active

CABERGOLINE 0.500 Mg ; in Africa — Regulatory Overview

CABERGOLINE 0.500 Mg ; is registered across 1 African markets with 13 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Egypt. AfricaRegulatory refreshes this data daily from official government sources.

Of the 13 registrations, 13 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.